Skip to main content
See every side of every news story
Published loading...Updated

FDA warns J&J vaccine plant in South Korea following 2024 inspection

Summary by endpoints.news
The FDA has raised questions about a Johnson & Johnson vaccine manufacturing site in South Korea, saying the facility failed to investigate "recurring complaints" related to product quality. The July 8
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

endpoints.news broke the news in on Tuesday, September 23, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal